313 related articles for article (PubMed ID: 11519011)
1. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.
Waterham HR; Koster J; Romeijn GJ; Hennekam RC; Vreken P; Andersson HC; FitzPatrick DR; Kelley RI; Wanders RJ
Am J Hum Genet; 2001 Oct; 69(4):685-94. PubMed ID: 11519011
[TBL] [Abstract][Full Text] [Related]
2. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
[TBL] [Abstract][Full Text] [Related]
3. Desmosterolosis and desmosterol homeostasis in the developing mouse brain.
Allen LB; Genaro-Mattos TC; Porter NA; Mirnics K; Korade Z
J Inherit Metab Dis; 2019 Sep; 42(5):934-943. PubMed ID: 30891795
[TBL] [Abstract][Full Text] [Related]
4. Desmosterolosis-phenotypic and molecular characterization of a third case and review of the literature.
Schaaf CP; Koster J; Katsonis P; Kratz L; Shchelochkov OA; Scaglia F; Kelley RI; Lichtarge O; Waterham HR; Shinawi M
Am J Med Genet A; 2011 Jul; 155A(7):1597-604. PubMed ID: 21671375
[TBL] [Abstract][Full Text] [Related]
5. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay.
Andersson HC; Kratz L; Kelley R
Am J Med Genet; 2002 Dec; 113(4):315-9. PubMed ID: 12457401
[TBL] [Abstract][Full Text] [Related]
6. Desmosterolosis presenting with multiple congenital anomalies.
Rohanizadegan M; Sacharow S
Eur J Med Genet; 2018 Mar; 61(3):152-156. PubMed ID: 29175559
[TBL] [Abstract][Full Text] [Related]
7. DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis.
Mirza R; Hayasaka S; Takagishi Y; Kambe F; Ohmori S; Maki K; Yamamoto M; Murakami K; Kaji T; Zadworny D; Murata Y; Seo H
J Invest Dermatol; 2006 Mar; 126(3):638-47. PubMed ID: 16410790
[TBL] [Abstract][Full Text] [Related]
8. First case of desmosterolosis diagnosed by prenatal whole exome sequencing.
Hill C; Noureldein M; Karkhanis P; Kinning E; Vijay S; Gowda H
Am J Med Genet A; 2023 Mar; 191(3):859-863. PubMed ID: 36538928
[TBL] [Abstract][Full Text] [Related]
9. Exploiting
Cocciadiferro D; Mazza T; Vecchio D; Biagini T; Petrizzelli F; Agolini E; Villani A; Minervino D; Martinelli D; Rizzo C; Boenzi S; Panfili FM; Buonuomo PS; Macchiaiolo M; Bartuli A; Novelli A
Front Genet; 2023; 14():1307934. PubMed ID: 38239854
[TBL] [Abstract][Full Text] [Related]
10. Generation and validation of a conditional knockout mouse model for desmosterolosis.
Kanuri B; Fong V; Ponny SR; Weerasekera R; Pulakanti K; Patel KS; Tyshynsky R; Patel SB
J Lipid Res; 2021; 62():100028. PubMed ID: 33524375
[TBL] [Abstract][Full Text] [Related]
11. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.
Waterham HR; Wijburg FA; Hennekam RC; Vreken P; Poll-The BT; Dorland L; Duran M; Jira PE; Smeitink JA; Wevers RA; Wanders RJ
Am J Hum Genet; 1998 Aug; 63(2):329-38. PubMed ID: 9683613
[TBL] [Abstract][Full Text] [Related]
12. Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.
Luu W; Zerenturk EJ; Kristiana I; Bucknall MP; Sharpe LJ; Brown AJ
J Lipid Res; 2014 Mar; 55(3):410-20. PubMed ID: 24363437
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of aquaporin-3 in the epidermis of DHCR24 knockout mice.
Mirza R; Hayasaka S; Kambe F; Maki K; Kaji T; Murata Y; Seo H
Br J Dermatol; 2008 Apr; 158(4):679-84. PubMed ID: 18241265
[TBL] [Abstract][Full Text] [Related]
14. Desmosterol in brain is elevated because DHCR24 needs REST for Robust Expression but REST is poorly expressed.
Tint GS; Pan L; Shang Q; Sharpe LJ; Brown AJ; Li M; Yu H
Dev Neurosci; 2014; 36(2):132-42. PubMed ID: 24861183
[TBL] [Abstract][Full Text] [Related]
15. Desmosterolosis: an illustration of diagnostic ambiguity of cholesterol synthesis disorders.
Dias C; Rupps R; Millar B; Choi K; Marra M; Demos M; Kratz LE; Boerkoel CF
Orphanet J Rare Dis; 2014 Jun; 9():94. PubMed ID: 24961299
[TBL] [Abstract][Full Text] [Related]
16. The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with agenesis of corpus callosum and loss of white matter.
Zolotushko J; Flusser H; Markus B; Shelef I; Langer Y; Heverin M; Björkhem I; Sivan S; Birk OS
Eur J Hum Genet; 2011 Sep; 19(9):942-6. PubMed ID: 21559050
[TBL] [Abstract][Full Text] [Related]
17. Promoter analysis of the DHCR24 (3β-hydroxysterol Δ(24)-reductase) gene: characterization of SREBP (sterol-regulatory-element-binding protein)-mediated activation.
Daimiel LA; Fernández-Suárez ME; Rodríguez-Acebes S; Crespo L; Lasunción MA; Gómez-Coronado D; Martínez-Botas J
Biosci Rep; 2012 Dec; 33(1):57-69. PubMed ID: 23050906
[TBL] [Abstract][Full Text] [Related]
18. The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1).
Zerenturk EJ; Kristiana I; Gill S; Brown AJ
Biochim Biophys Acta; 2012 Sep; 1821(9):1269-77. PubMed ID: 22178193
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening of Novel 24-Dehydroxysterol Reductase (
Wang H; Lu Z; Li Y; Liu T; Zhao L; Gao T; Lu X; Gao B
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985615
[TBL] [Abstract][Full Text] [Related]
20. Dehydrocholesterol Reductase 24 (DHCR24): Medicinal Chemistry, Pharmacology and Novel Therapeutic Options.
Müller C; Hank E; Giera M; Bracher F
Curr Med Chem; 2022; 29(23):4005-4025. PubMed ID: 34781860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
